Brief: X4 Pharmaceuticals Announces Pricing Of $135 Million Underwritten Public Offering At $2.90 Per Share
24/10/2025 05:39
Oct 24 (Reuters) - X4 Pharmaceuticals Inc XFOR.O: X4 PHARMACEUTICALS ANNOUNCES PRICING OF $135 MILLION UNDERWRITTEN PUBLIC OFFERING X4 PHARMACEUTICALS INC - PRICES PUBLIC OFFERING AT $2.90 PER SHARE Source text: ID:nGNX8VjGHx Further company coverage: XFOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule